Stock comparison
INCYTE CORP is 1.5x more valuable than Medpace Holdings, Inc. by market capitalization ($23.68 B vs $15.29 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
INCY is larger
INCYTE CORP is 1.5x more valuable than Medpace Holdings, Inc. by market capitalization ($23.68 B vs $15.29 B).
Market value leader
INCY
INCYTE CORP is 1.5x more valuable than Medpace Holdings, Inc. by market capitalization ($23.68 B vs $15.29 B).
Revenue leader
INCY
INCY: $5.14B vs MEDP: $2.53B.
Profit leader
INCY
INCY: $1.29B vs MEDP: $451.12M.
Margin leader
INCY
INCY: 25.0% vs MEDP: 17.8% net margin.
| Metric | INCY | MEDP |
|---|---|---|
| Market cap | $23.68 B | $15.29 B |
| US-listed rank | #563 | #731 |
| Revenue (latest FY) | $5.14B | $2.53B |
| Net income (latest FY) | $1.29B | $451.12M |
| Net margin | 25.0% | 17.8% |
| P/E (trailing FY) | 18.4x | 33.9x |
| SEC filings | 2,536 | 874 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
INCYTE CORP is 1.5x more valuable than Medpace Holdings, Inc. by market capitalization ($23.68 B vs $15.29 B).
In their latest fiscal years, INCYTE CORP reported $5.14B in revenue while Medpace Holdings, Inc. reported $2.53B.
Full pages: INCYTE CORP and Medpace Holdings, Inc., or browse the full rankings.